LOS ANGELES, April 29, 2011 /PRNewswire/ -- UBM Canon's Medical Design Excellence Awards has announced the winner of the Medical Design Excellence Awards (MDEA) Lifetime Achievement Award. This award honors an individual whose contributions during a long career have had a demonstrable impact on technological, business, and cultural advancements in medical devices.
Selected by the entire UBM Canon Medical Content Team and the Medical Device and Diagnostic Industry Editorial Advisory Board, Alfred E. Mann, Chairman and CEO of MannKind Corporation, has been chosen as this award's first recipient. Mr. Mann has dedicated the past 42 years to the development of medical device technologies. His current company, MannKind Corporation, is a diversified biopharmaceutical company focused on the development of novel therapeutics and drug delivery technologies for treatment of diabetes, cancer, autoimmune and inflammatory diseases. MannKind's lead product, AFREZZA, mimics the insulin kinetics of a normal pancreas, creating a new therapy paradigm for diabetes.